Iradimed CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

6 Mar 2026

IRMD

10-K: IRadimed Reports Strong 2025 Growth, New Facility & Product Innovation

IRadimed Corporation announced robust financial results for fiscal year 2025, driven by increased sales of its MRI-compatible medical devices and the launch of its new MRidium 3870 IV infusion pump system.

NASDAQ

4 Sept 2025

IRMD

Iradimed CORP

10-K/A: IRADIMED Amends 10-K, Reports Strong 2024 Financials

IRADIMED Corporation filed an amended annual report for 2024, correcting a certification omission while reporting significant revenue and profit growth driven by domestic sales.

NASDAQ

6 Mar 2025

IRMD

Iradimed CORP

10-K: IRADIMED Corporation Reports Strong Financial Results for 2024, Revenue Climbs to $73.2 Million

IRADIMED Corporation's 2024 annual report reveals a 12% increase in revenue, reaching $73.2 million, driven by growth in MRI compatible medical device sales.

NASDAQ

1 Mar 2024

IRMD

Iradimed CORP

10-K: IRADIMED Corporation Reports Strong 2023 Financial Results Driven by Increased Demand for MRI Compatible Devices

IRADIMED Corporation's 2023 annual report reveals a significant increase in revenue and profitability, driven by strong sales of its MRI compatible medical devices.